المؤلفون: Quaglino P, Ascierto PA, Consoli F, Queirolo P, Spagnolo F, Morelli MF, Berardi R, Chiarion-Sileni V, Tucci M, Troiani T, Melotti B, Rossi E, Mandala M, Rinaldi G, Marcon IG, Pizzuti M, Del Vecchio M

المصدر: Cancer Management and Research, Vol Volume 15, Pp 1271-1281 (2023)

مصطلحات موضوعية: braf mutation, dabrafenib, melanoma, real-world, trametinib, managed access program, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.dovepress.com/characteristics-of-real-world-patients-with-high-risk-brafv600ek-mutat-peer-reviewed-fulltext-article-CMAR; https://doaj.org/toc/1179-1322

URL الوصول: https://doaj.org/article/61e573f959ce4c9193d56a436410e730

المؤلفون: Ghedini, Pietro^Aff1, Bossert, I.^{Aff1, Aff2}, Zanoni, L., Ceci, F., Graziani, T., Castellucci, P., Ambrosini, V., Massari, F., Nobili, E., Melotti, B., Musto, A., Zoboli, S., Antunovic, L., Kirienko, M., Chiti, A., Mosconi, C., Ardizzoni, A., Golfieri, R., Fanti, S., Nanni, C.

المصدر: European Journal of Nuclear Medicine and Molecular Imaging. 45(5):751-758

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: De Giglio, A., de Biase, D., Di Federico, A., Maloberti, T., Casadio, C., Gruppioni, E., Altimari, A., Melotti, B., Sperandi, F., Gelsomino, F., Ardizzoni, A.

المصدر: In Annals of Oncology October 2023 34 Supplement 2:S836-S836

المؤلفون: Martoni, A.A., Melotti, B., Sperandi, F., Giaquinta, S., Piana, E., Pavesi, L., Da Prada, G., Lelli, G.

المصدر: In Lung Cancer 2008 60(3):387-392

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Gelsomino, F., Fiorentino, M., Zompatori, M., Poerio, A., Melotti, B., Sperandi, F., Gargiulo, M., Borghi, C., Ardizzoni, A.

المصدر: In Annals of Oncology January 2018 29(1):284-286

المؤلفون: Ravaud, A, Motzer, Rj, Pandha, Hs, George, Dj, Pantuck, Aj, Patel, A, Chang, Yh, Escudier, B, Donskov, F, Magheli, A, Carteni, G, Laguerre, B, Tomczak, P, Breza, J, Gerletti, P, Lechuga, M1, Lin, X, Martini, Jf, Ramaswamy, K, Casey, M, Staehler, M, Patard, Jj, Gruenwald, V, Link, K, Doehn, C, Heinzer, H, Grimm, M-O, Wirth, M, Stoeckle, M, Heidenreich, A, Garcia del Muro Solans, X, Mellado, Bo, Castellano, Dg, Frydenberg, M, Schobinger, Sr, Dimopoulos, Ma, Rothermundt, C, Climent Duran MA, Melotti, B, Procopio, G, Boccardo, F, Sella, A, Stewart, S, Adenis, A, Jones, Rj, Chevreau, C, Prausova, J, Vyzula, R, Oudard, S, Jacqmin, D, Gravis, G, Varela, R, Herrmann, E, Lim, Hy, Lee, J-L, Kim, Yh, Kim, Jh, Y-C, Ou, Papakotoulas, P, Iacobelli, S, Chowdhury, S, Passalacqua, R, Tomasek, J, Anton Aparicio LM, Linassier, C, Hauser, S, Bergmann, L, Hawkins, Re, Szczylik, C, Zdrojowy, R, Sosnowski, M, Koralewski, P, Wiechnio, Pj, Schraml, J, Mardiak, J, Laurinc, P, Kliment, J, Rosenbaum, E, Lundstam, S, Flodgren, P, Ljungberg, B, Stenzl, A, Schnoeller, Tj, Mcdermott, Sr, Breathnach, Os, Mccaffrey, Ja, Donnellan, P, The, G-C, Rolland, F, Brekkan, E, Nilsson, C, Kim, Wy, Bishoff, J, Chung, J, Shore, Nd, Master, V, Tang Chen DY, Ye, D, Huang, Y, Jin, J, Song, B, Zhou, F, Galceran, Jc, Yao, X, Zhang, X.

المصدر: Ravaud, A, Motzer, R J, Pandha, H S, George, D J, Pantuck, A J, Patel, A, Chang, Y-H, Escudier, B, Donskov, F, Magheli, A, Carteni, G, Laguerre, B, Tomczak, P, Gerletti, P, Lechuga, M, Lin, X, Martini, J-F, Ramaswamy, K, Casey, M, Staehler, M, Patard, J-J & S-TRAC Investigators 2016, ' Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy ', The New England Journal of Medicine, vol. 375, no. 23, pp. 2246-2254 . https://doi.org/10.1056/NEJMoa1611406

مصطلحات موضوعية: Male, Indoles, medicine.medical_treatment, Clinical Trial, Phase III, 030232 urology & nephrology, Nephrectomy, 0302 clinical medicine, Renal cell carcinoma, Clinical endpoint, 80 and over, Adjuvant, Aged, 80 and over, Adolescent, Adult, Aged, Antineoplastic Agents, Carcinoma, Renal Cell, Chemotherapy, Adjuvant, Double-Blind Method, Drug Administration Schedule, Female, Humans, Kidney Neoplasms, Middle Aged, Pyrroles, Survival Analysis, Young Adult, Medicine (all), Sunitinib, General Medicine, Multicenter Study, 030220 oncology & carcinogenesis, Randomized Controlled Trial, medicine.drug, medicine.medical_specialty, Urology, Placebo, 03 medical and health sciences, Journal Article, Carcinoma, medicine, Chemotherapy, Survival analysis, business.industry, Renal Cell, medicine.disease, Surgery, Clinical trial, business

وصف الملف: text

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::044148e0163ba78bfbd9d2be3de578c8
https://surrey.eprints-hosting.org/812586/